Background Sarcopenia is a disease associated with aging and a negative prognosis.
Consensus‐based treatment consists in targeting muscle mass and function through …

Sarcopenia refers to age‐associated decrease in muscle mass and function. The condition
was originally described in the elderly, but emerging evidence suggests that it is also a …

A decline in muscle mass and function represents one of the most problematic changes
associated with aging, and has dramatic effects on autonomy and quality of life. Several …

Sarcopenia, the loss of skeletal muscle mass and function with aging, is a multifactorial
condition that slowly develops over decades and becomes a significant contributor to …

Sarcopenia, the age-related loss of muscle mass and strength, is a fundamental cause of
frailty, functional decline and disability. In the year 2000, $18.5 billion in health care costs …

Background Sarcopenia is strongly associated with an inadequate intake of dietary protein.
Dietary protein supplementation boosts muscle-protein synthesis and increases muscle …

Age-related sarcopenia, composed of myopenia (a decline in muscle mass) and dynapenia
(a decline in muscle strength), can compromise physical function, increase risk of disability …

Preserving or restoring adequate nutritional status is a key factor to delay the onset of
chronic diseases and to accelerate recovery from acute illnesses. In particular, consistent …

One of the many threats to independent life is the age-related loss of muscle mass and
muscle function commonly referred to as sarcopenia. Another important health risk in old …

At the present time, there is only limited understanding of the public health significance of
sarcopenia. The well-recognized functional consequences of sarcopenia include gait and …